SCHEMBL22809555

SCHEMBL22809555

CC(CN)Oc1ccc(C(F)(F)F)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 5/20 0.50
SLC6A2 P23975 4/20 0.50
SLC6A3 Q01959 4/20 0.50
KCNK2 O95069 2/20 0.50
KCNH2 Q12809 2/20 0.50
CACNA1C Q13936 2/20 0.50
SLC7A5 Q01650 6/20 0.47
MAOB P27338 1/20 0.44
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
LMNA P02545 4/20 0.43
HRH3 Q9Y5N1 2/20 0.43
NPC1 O15118 2/20 0.43
CYP2D6 P10635 2/20 0.43
CYP2C19 P33261 2/20 0.43
MTOR P42345 2/20 0.43
RAB9A P51151 2/20 0.43
CYP3A4 P08684 2/20 0.43
HTR2C P28335 2/20 0.43
KDM4E B2RXH2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15473214 0.83 SLC6A4 (0.44) SLC6A4SLC6A2SLC6A3KCNK2KCNH2
SCHEMBL18071748 0.81 SLC6A4 (0.43) SLC6A4SLC6A2SLC6A3KCNK2KCNH2
SCHEMBL7018753 0.81 PPARG (0.45) SLC6A4SLC6A2SLC6A3KCNK2KCNH2
SCHEMBL12958117 0.80 SLC6A4 (0.42) SLC6A4SLC6A2SLC6A3KCNK2KCNH2
SCHEMBL11611228 0.79 SLC6A4 (0.44) SLC6A4SLC6A2SLC6A3KCNK2KCNH2
SCHEMBL250835 0.79 SLC6A4 (0.44) SLC6A4SLC6A2SLC6A3KCNK2KCNH2
SCHEMBL223867 0.79 SLC6A4 (0.44) SLC6A4SLC6A2SLC6A3KCNK2KCNH2
SCHEMBL22809558 0.79 SLC6A4 (0.55) SLC6A4SLC6A2SLC6A3KCNK2KCNH2
SCHEMBL250952 0.79 SLC6A4 (0.44) SLC6A4SLC6A2SLC6A3KCNK2KCNH2
SCHEMBL10850804 0.79 ALDH1A1 (0.47) SLC6A4MAOBALDH1A1PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110612285-B Amide derivatives as Nav1.7 and Nav1.8 blockers 拉夸里亚创药株式会社 2023-04-04 CN disclosed
US-11154544-B2 Amide derivatives as Nav1.7 and Nav1.8 blockers RAQUALIA PHARMA INC. (JP) 2021-10-26 US disclosed
EP-3487839-B1 AMIDE DERIVATIVES AS NAV1.7 AND NAV1.8 BLOCKERS RAQUALIA PHARMA INC (JP) 2020-12-23 EP disclosed
CN-110612285-A Amide derivatives as Nav1.7 and Nav1.8 blockers 拉夸里亚创药株式会社 2019-12-24 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11154544-B2 Amide derivatives as Nav1.7 and Nav1.8 blockers SCN8A, SCN7A, SCN1A SLC6A4 335/4885SLC6A2 160/4885SLC6A3 317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.